Vascular Stents Market is Expected to Reach US$ 17.1 Billion by 2032- IMARC Group

The latest report by IMARC Group, titled "𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞 (𝐂𝐨𝐫𝐨𝐧𝐚𝐫𝐲 𝐒𝐭𝐞𝐧𝐭𝐬, 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐒𝐭𝐞𝐧𝐭𝐬, 𝐄𝐯𝐚𝐫 𝐒𝐭𝐞𝐧𝐭 𝐆𝐫𝐚𝐟𝐭𝐬), 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥 (𝐌𝐞𝐭𝐚𝐥𝐥𝐢𝐜 𝐒𝐭𝐞𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐌𝐨𝐝𝐞 𝐨𝐟 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 (𝐁𝐚𝐥𝐥𝐨𝐨𝐧-𝐄𝐱𝐩𝐚𝐧𝐝𝐚𝐛𝐥𝐞 𝐒𝐭𝐞𝐧𝐭𝐬, 𝐒𝐞𝐥𝐟-𝐄𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐒𝐭𝐞𝐧𝐭𝐬), 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫 (𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 𝐚𝐧𝐝 𝐂𝐚𝐫𝐝𝐢𝐚𝐜 𝐂𝐞𝐧𝐭𝐞𝐫𝐬, 𝐀𝐦𝐛𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐂𝐞𝐧𝐭𝐞𝐫𝐬), 𝐚𝐧𝐝 𝐑𝐞𝐠𝐢𝐨𝐧 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐", The global vascular stents market size reached US$ 10.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032

𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐀𝐟𝐟𝐞𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐒𝐭𝐞𝐧𝐭𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐈𝐧𝐜𝐢𝐝𝐞𝐧𝐜𝐞 𝐨𝐟 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬:

The primary driver behind the growth of the vascular stents market is the rising incidence of cardiovascular diseases (CVDs) worldwide. CVDs, which include conditions such as coronary artery disease and peripheral artery disease, continue to be a leading cause of morbidity and mortality globally. The aging population, sedentary lifestyles, and dietary habits contribute to the higher prevalence of CVDs. With a growing number of patients diagnosed with cardiovascular conditions, there is an increased demand for interventional cardiology procedures, including the placement of vascular stents. These stents help to open narrowed or blocked arteries, restoring blood flow and reducing the risk of complications. As a result, the vascular stent market is witnessing significant expansion to meet the escalating healthcare needs of the aging population and those at risk of CVDs.

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐒𝐭𝐞𝐧𝐭 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲:

Advancements in stent technology have revolutionized the vascular stents market. Manufacturers have been consistently innovating to improve the safety and efficacy of stents, leading to the development of drug-eluting stents (DES) and bioresorbable stents. DES, for instance, are coated with medications that help prevent restenosis, a common problem in which arteries narrow again after stent placement. Furthermore, bioresorbable stents are designed to gradually dissolve in the body, eliminating the need for a permanent implant. These innovations have enhanced patient outcomes, reduced complications, and led to shorter recovery times, making stent implantation a more attractive option for both patients and healthcare providers.

𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐀𝐠𝐢𝐧𝐠 𝐏𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧:

The global demographic shift toward an aging population is another significant factor driving the vascular stents market. As individuals age, they are more prone to developing various cardiovascular conditions due to factors such as arterial aging and plaque buildup. This demographic trend has resulted in a higher demand for cardiovascular interventions, including the placement of vascular stents. Moreover, older adults often have multiple comorbidities, making them candidates for complex coronary and peripheral artery procedures, where stents play a crucial role in restoring and maintaining blood flow. The aging population increases the number of potential patients and also drives research and development efforts to create stents tailored to the specific needs of elderly individuals, further fueling market growth.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐰𝐢𝐭𝐡 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫:

Medtronic Plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik Se & Co. Kg
Braun Melsungen Ag
Terumo Corporation
Microport Scientific Corporation
Meril Life Sciences Pvt. Ltd.
Vascular Concepts Limited
C.R. Bard Inc.
W.L. Gore and Associates Inc.
Endologix, Inc.
Lombard Medical
Translumina Gmbh
Jotec Gmbh

𝐅𝐨𝐫 𝐚𝐧 𝐢𝐧-𝐝𝐞𝐩𝐭𝐡 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐫𝐞𝐟𝐞𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/vascular-stents-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞:

Coronary Stents 
Peripheral Vascular Stents
Evar Stent Grafts

Coronary stents dominate the market due to the high prevalence of coronary artery disease and the widespread adoption of coronary stents as a standard intervention for restoring blood flow in coronary arteries, making it the dominant category in the stent market.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥:

Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others

Metallic stents hold maximum number of shares due to their proven durability, flexibility, and effectiveness in maintaining vessel patency, making them the preferred choice for a wide range of cardiovascular interventions.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐌𝐨𝐝𝐞 𝐨𝐟 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲:

 Balloon-Expandable Stents
 Self-Expanding Stents

Balloon-expandable stents represent the largest segment due to their precise and controlled deployment, which allows for effective treatment of narrowed or blocked arteries, making them a preferred choice for interventional procedures.

𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫:

Hospitals and Cardiac Centers
Ambulatory Surgical Centers

Hospitals and cardiac centers dominate the market due to their central role in providing comprehensive cardiovascular care, including diagnosis, treatment, and surgical interventions, making them primary users of vascular stents.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐁𝐫𝐞𝐚𝐤𝐮𝐩 𝐛𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

North America's dominance in the vascular stents market is attributed to its robust healthcare infrastructure, high prevalence of cardiovascular diseases, and substantial investments in medical research and innovation.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐓𝐚𝐛𝐥𝐞 𝐨𝐟 𝐂𝐨𝐧𝐭𝐞𝐧𝐭𝐬: https://www.imarcgroup.com/vascular-stents-market

𝐆𝐥𝐨𝐛𝐚𝐥 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐒𝐭𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

The vascular stents market is dynamic, with companies continually developing and launching new stent products. Regulatory approvals for these innovations are crucial in driving market growth. As new stents with improved features and efficacy gain regulatory clearance, they enter the market, offering more options to healthcare providers and patients. Additionally, technological advancements in imaging techniques, such as angiography and intravascular ultrasound (IVUS), are playing a significant role in the vascular stents market. These advanced imaging tools allow healthcare professionals to precisely diagnose and assess vascular conditions, helping them select the most appropriate stent type and placement strategy. This results in improved patient outcomes and drives the demand for vascular stents.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

https://www.imarcgroup.com/detox-drinks-market
https://www.imarcgroup.com/delivery-drones-market
https://www.imarcgroup.com/alopecia-treatment-market
https://www.imarcgroup.com/pet-accessories-market
https://www.imarcgroup.com/wires-cables-market

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.